Advertisement

High-Performance Liquid Chromatographic Analysis of Antidepressants, Neuroleptics, and Benzodiazepines

  • Donald F. LeGatt
Part of the Neuromethods book series (NM, volume 10)

Abstract

Whether one is a toxicologist attempting to confirm drug overdose or establish cause of death, a physician/clinical chemist seeking to correlate clinical response with a serum level, or a research scientist collecting pharmacokinetic data, precise accurate analytical methods for drugs are required. Such a method, highperformance liquid chromatography (HPLC), has become an invaluable analytical tool not only in the research environment, but in clinical and forensic laboratories as well. This technique has been applied extensively to the qualitative and quantitative analysis of three groups of widely prescribed and abused mood-altering drugs-the antidepressants, neuroleptics, and benzodiazepmes. This chapter will review the types of HPLC procedures available for the three drug groups, concentrating on methods published within the last 7 yr. Considerations pertaining to specimen collection, storage, and handling and specimen preparation prior to chromatography will be addressed. Detailed evaluations of individual methods will not be done, and the appropriate articles should be searched for more specific information.

Keywords

Parent Drug Adsorption Chromatography HPLC Procedure Simultaneous Quantitation Minimum Therapeutic Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aaes-Jorgensen T. (1980) Specific high-performance liquid chromatographic method for estimation of the cis(Z)-and trans(E)-isomers of clopenthixol and a N-dealkyl metabolite. J. Chromatogr. Biomed. Appl. 183, 239–245.Google Scholar
  2. Adams W. I., Bombardt P. A., and Brewer J. E (1984) Normal-phase liquid chromatographic determination of alprazolam in human serum. Anal. Chem 56, 1590–1594.PubMedGoogle Scholar
  3. Allender W. J. (1985) High-pressure liquid chromatographic determination of thioridazine and its major metabolites in biological tissues and fluids. J. Chromatogr. Sci. 24, 541–545.Google Scholar
  4. Allender W. J. and Archer A. W. (1984) Liquid chromatographic analysis of promethazme and its major metabolites in human postmortem material. J, Forens Sci. 29, 515–526.Google Scholar
  5. Allender W. J., Archer A. W., and Dawson A. G. (1983) Extraction and analysis of chlorpromazine and its major metabolites in post mortem material by enzymic digestion and HPLC. J. Anal. Toxicol. 7, 203–206.PubMedGoogle Scholar
  6. Ankier S. I., Martin B. K., Rogers M. S., Carpenter P. K., and Graham C. (1981) Trazodone-a new assay procedure and some pharmacokinetic parameters. Br. J. Clin. Pharmacol 11, 505–509.PubMedGoogle Scholar
  7. Ascalone V. (1980) Determination of chlordiazepoxide and its metabolites in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr Biomed. Appl. 181, 141–146.Google Scholar
  8. Bannister S. J., van der Wai Sj., Dolan J. W., and Synder L R. (1981) Liquid-chromatographic analysis for common tricyclic antidepressant drugs and their metabolites in serum or plasma with the Technicon “FAST-LC” system. Clin. Chem. 27, 849–855.PubMedGoogle Scholar
  9. Beierle F. A. and Hubbard R. W (1983a) Liquid chromatographic separation of antidepressant drugs. I. tricychcs. Ther. Drug Monit. 5, 279–292.PubMedGoogle Scholar
  10. Beierle F. A. and Hubbard R. W (1983b) Liquid chromatographic separation of antidepressant drugs. II Amoxapine and maprotiline. Ther. Drug Monit 5, 293–301.PubMedGoogle Scholar
  11. Bell J. L. (1985) Methods for monitoring neuroleptic drugs. Am. Assoc. Clin Chem. TDM-T 6, 1–6.Google Scholar
  12. Biggs S. R., Brodie R. R., Hawkins D R, and Midgley I. (1977) The Use of High Pressure Liquid Chromatography and Mass Spectrometry for the Analysis of Amitriptyline and Its Metabolites in Plasma, in Clinical Toxicology vol. 18 (Leonard B. J. and Duncan W. A. M., eds.) Excerpta Medica, Elsevier, Amsterdam.Google Scholar
  13. Biggs S. R., Chasseaud L. F., Hawkins D. R., and Midgley I. (1979) Determination of amitriptyline and its major basic metabolites in human urine by high-performance liquid chromatography. Drug Metab. Dispos 7, 233–236.PubMedGoogle Scholar
  14. Blanc M., Tran M.-A., and Cotonat J. (1983) Technique de dosage de trois antidepresseurs tricycliques par chromatographie liquide haute performance. Therapie 38, 17–20.PubMedGoogle Scholar
  15. Bock J. L, Giller E., Gray S., and Jatlow P. (1982) Steady-state plasma concentrations of cis-and trans-10-OH amitriptyline metabolites. Clin Pharmacol Ther. 31, 609–616.PubMedGoogle Scholar
  16. Bogema S. C, Narasimhachari N., Mumtaz M., Goldin S., and Friedel R. O. (1982) Separation and quantitation of cis-and trans-thiothixene in human plasma by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 233, 257–267.Google Scholar
  17. Borga O., Piafsky K. M., and Nilsen O. G. (1977) Plasma protein binding of basic drugs. Clin. Pharmacol. Ther. 22, 539–544.PubMedGoogle Scholar
  18. Brachet-Liermain A, Jarry Ch., Faure O., Guyot M., and Loiseau P. (1982) Liquid chromatography determination of clobazam and its major metabolite N-desmethylclobazam in human plasma. Ther. Drug Momt. 4, 301–305.Google Scholar
  19. Breutzmann D. A. and Bowers L. D. (1981) Reversed-phase liquid chromatography and gas chromatography/mass fragmentography compared for determination of tricyclic antidepressant drugs. Clin. Chem. 27, 1907–1911.PubMedGoogle Scholar
  20. Breyer-Pfaff U., Wiatr R., and Nill K. (1984) Measurement of maprotiline and oxaprotiline in plasma by high-performance liquid chromatography of fluorescent derivatives. J. Chromatogr. Biomed. Appl. 309, 107–114.Google Scholar
  21. Brinkman U. A., Welling P. L. M, De Vries G., Scholten A. H. M. T., and Frei R. W. (1981) Liquid chromatography of demoxepam and phenothiazines using a post-column photochemical reactor and fluorescence detection. J. Chromatogr. Biomed Appl. 217, 463–471.Google Scholar
  22. Brodie R. R., Chasseaud L. F., and Hawkins D. R. (1977a) Separation and measurement of tricyclic antidepressant drugs in plasma by highperformance liquid chromatography. J. Chromatogr. Biomed. Appl. 143, 535–539.Google Scholar
  23. Brodie R. R., Chasseaud L. F., Crampton E L., Hawkins D. R., and Risdall P. C (1977b) High performance liquid chromatographic determination of dothiepin and northiaden in human plasma and serum J Int. Med Res. 5, 387–390.PubMedGoogle Scholar
  24. Brodie R. R., Chasseaud L. F., and Taylor T. (1978) High-performance liquid chromatographic determination of benzodiazepines in human plasma. J. Chromatogr. 150, 361–366.PubMedGoogle Scholar
  25. Brooks M. A., DiDonato G., and Blumenthal H. P. (1985) Determination of chlorprothixene and its sulfoxide metabolite in plasma by highperformance liquid chromatography with ultraviolet and amperometric detection. J. Chromatogr. Biomed. Appl. 337, 351–362.Google Scholar
  26. Browning J. L., Harrington C A., Burch N. R., and Davis C. M. (1982) Quantification of halopendol and reduced halopendol metabolites in plasma of psychiatric patients. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41, 1635.Google Scholar
  27. Caldwell R. and Flanagan R. J. (1985) Measurement of trazodone in biological fluids by high performance liquid chromatographyJ Chromatogr. Biomed Appl. 345, 187–191.Google Scholar
  28. Cole-Parmer Instrument Co. (1986) New HPLC column for fast drug analysis. Information brochure CHR-NP, Chicago, Illinois.Google Scholar
  29. Colin P., Sirois G., and Lelorier J. (1983) High-performance liquid chromatography determination of dipotassium clorazepate and its major metabolite nordiazepam in plasma. J. Chromatogr. Biomed. Appl. 273, 367–377.Google Scholar
  30. Cooper J. K., McKay G., and Midha K. K. (1983) Subnanogram quantitation of chlorpromazine in plasma by high-performance liquid chromatography with electrochemical detection. J. Pharm. Sci. 72, 1259–1262.PubMedGoogle Scholar
  31. Cotler S., Puglisi C. V., and Gustafson J. H. (1981) Determination of diazepam and its major metabolites in man and in the cat by highperformance liquid chromatography. J. Chromatogr. Biomed. Appl. 222, 95–106.Google Scholar
  32. Curry S. H., Brown E A., Hu O. Y.-P., and Perrin J. H (1982) Liquid chromatographic assay of phenothiazine, thioxanthene and butyrophenone neuroleptics and antihistamines in blood and plasma with conventional and radial compression columns and UV and electrochemical detection. J. Chromatogr. Biomed Appl. 231, 361–376.Google Scholar
  33. Davi H., Guyonnet J., Necciari J., and Cautreels W. (1985) Determination of circulating ethyl loflazepate metabolites in the baboon by radiohigh-performance liquid chromatography with injection of crude plasma samples. Comparison with solvent extraction and thin-layer chromatography. J. Chromatogr. Biomed. Appl 342, 159–165.Google Scholar
  34. Dawling S., Braithwaite R., and Crome P. (1979) Nomifensine overdose and plasma drug concentration. Lancet 1, 56.PubMedGoogle Scholar
  35. Dehass-Vermeulen J. and Thompson T. A. (1984) Assay for the determination of the tetracyclic antidepressant compound aptazapine in plasma by high performance liquid chromatography. J. Chromatogr. Biomed Appl. 306, 412–416.Google Scholar
  36. Desmond P. V., Roberts R. K, Wood A. J., Dunn G. D, Wilkinson G. R., and Schenker S (1980) Effect of heparin administration on plasma binding of benzodiazepines Br. J. Clin. Pharmacol. 9, 171–175.PubMedGoogle Scholar
  37. Dhar A. K. and Kutt H. (1984) Improved hquid-chromatographic determination of haloperidol in plasma. Clin. Chem. 30, 1228–1230.PubMedGoogle Scholar
  38. Diquet B., Gaudel G, Colin J. N, and Singlas E. (1982) Dosage plasmatique de la clomipramine et de la demethylclomipramine par chromatographie liquide à haute performance. Ann. Biol. Clin. (Paris) 40, 321–324.Google Scholar
  39. diTelia A. S., Ricci P., diNunzio C, and Cassandro P. (1986) A new method for the determination in blood and urine of a novel triazolobenzodiazepine (estazolarn) by HPLC. J Anal Toxicol. 10, 65–67.Google Scholar
  40. Divoll M., Greenblatt D. J., and Shader R. I. (1982) Liquid chromatographic determination of chlordiazepoxide and metabolites in plasma. Pharmacology 24, 261–266.PubMedGoogle Scholar
  41. Dixon R. and Martin D. (1981) Tricyclic antidepressants: A simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC Res. Commun. Chem Path Pharmacol 33, 537–545.Google Scholar
  42. Dorey R. C, Landa B. L, and Narasimhachari N (1983) Analysis of as-thiothixene in plasma by HPLC Clin Chem 29, 1210.Google Scholar
  43. Edelbroek P. M., deHaas E. J. M., and de Wolff F. A. (1982) Liquidchromatographic determination of amitriptyline and its metabolites in serum, with adsorption onto glass minimized. Clin. Chem. 28, 2143–2148.PubMedGoogle Scholar
  44. Edinboro L. E. and Backer R. C. (1985) Preliminary report on the application of a high performance liquid chromatographic method for alprazolam in postmortem blood specimens. J. Anal. Toxicol. 9, 207–208.PubMedGoogle Scholar
  45. Emanuelsson B. and Moore R. G. (1978) Quantitation of zimelidine and norzimelidine in plasma using high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 146, 113–119.Google Scholar
  46. Faulkner R. D. and Lee C. (1983) Comparative assays for doxepin and desmethyldoxepm using high-performance liquid chromatography and high-performance thin-layer chromatography. J Pharm. Sci. 72, 1165–1167.PubMedGoogle Scholar
  47. Fekete J., DelCastilho P., and Kraak J. C. (1981) Reversed-phase liquid chromatography for the separation of chlorpromazine, imipramine and some of their metabolites. J. Chromatogr. 204, 319–327.PubMedGoogle Scholar
  48. Foreman J. M., Griffiths W. C, Dextraze P. G., and Diamond I. (1980) Simultaneous assay of diazepam, chlordiazepoxide, N-desmethyldi-azepam, N-desmethylchlordiazepoxide, and demoxepam in serum by high performance liquid chromatography Clin Biochem. 13, 122–125.PubMedGoogle Scholar
  49. Gerson B., Chan S., Bell F., and Pappalardo K. M (1986) Trazodone: A simple, clean extraction and rapid quantification by high pressure liquid chromatography J. Psychiat. Res. 20, 69–76PubMedGoogle Scholar
  50. Gill R., Law B, and Gibbs J. P. (1986) High performance liquid chromatography systems for the separation of benzodiazepines and their metabolites. J. Chromatogr. 356, 37–46.PubMedGoogle Scholar
  51. Gillilan R. and Mason W. D (1981) High-pressure liquid chromatographic determination of viloxazine in human plasma and urine. J. Pharm. Sci. 70, 220–221.PubMedGoogle Scholar
  52. Glassman A H., Schildkraut J. J, Orsulak P. J, Cooper T. B., Kupfer D J., Shader R I., Davis J. M., Carroll B., Perel J. M., Klerman G. L., and Greenblatt J (1985) Tricyclic antidepressants-blood level measurements and clinical outcome An APA task force report. Am. J. Psychiatry 142, 155–162.Google Scholar
  53. Godbillon J. and Gauron S. (1981) Determination of clomipramine or lmipramine and their non-demethylated metabolites in human blood or plasma by high-performance liquid chromatography. J. Chromatogr. 204, 303–311.PubMedGoogle Scholar
  54. Goldstein S. A and VanVunakis H. (1981) Determination of fluphenazine, related phenothiazine drugs and metabolites by combined high-performance liquid chromatography and radioimmunoassay. J Pharmacol. Exp Ther 217, 36–43.PubMedGoogle Scholar
  55. Good T. J. and Andrews J. S. (1981) The use of bonded-phase extraction columns for rapid sample preparation of benzodiazepines and metabolites from serum for HPLC analysis. J. Chromatogr. Sci. 19, 562–566.PubMedGoogle Scholar
  56. Gottschalk L. A., Dinvovo E., Biener R., and Nandi B. R. (1978) Plasma concentrations of thioridazine metabolites and ECG determinations. J. Pharm. Sci 67, 155–157.PubMedGoogle Scholar
  57. Grassi E., Passetti G L, and Trebbi A. (1977) Quantitative determination of pinazepam and its metabolites in blood and urine by highperformance liquid chromatography. J. Chromatogr. 144, 132–135.PubMedGoogle Scholar
  58. Greizerstein H. B. and Wojtowicz C. (1977) Simultaneous determination of chlordiazepoxide and its N-demethyl metabolite in 50-µL blood samples by high pressure liquid chromatography. Anal. them. 49, 2235–2236Google Scholar
  59. Gupta R. N. and Lew M. (1985) Determination of trazodone in human plasma by liquid chromatography with fluorescence detection. J Chromatogr. Biomed. Appl 342, 442–446Google Scholar
  60. Gupta R. N., Bartolucci G., and Molnar G. (1981) Analysis of chlorpromazine in plasma: Effect of specimen storage. Clin. Chim Acta. 109, 351–354.PubMedGoogle Scholar
  61. Hackett L. P. and Dusci L. J. (1979) The use of high-performance liquid chromatography in clinical toxicology. II. Tricyclic antidepressants Clin. Toxicol 15, 55–61.PubMedGoogle Scholar
  62. Hackman M. R. and Brooks M. A. (1981) Differential pulse amperometric detection of drugs in plasma using a dropping mercury electrode as a high-performance liquid chromatographic detector. J Chromatogr. Biomed. Appl. 222, 179–190.Google Scholar
  63. Hale P. W. and Poklis A. (1984) Determination of diastereoisomeric pairs of thiondazine 5-sulfoxide by high-performance liquid chromatography. J. Chromatogr. Biomed Appl. 336, 452–455.Google Scholar
  64. Hawes E. M, Hubbard J. W., Martin M., McKay G., Yeung P. K. F., and Midha K. K (1986) Therapeutic monitoring of chlorpromazine. III. Minimal interconversion between chlorpromazine and metabolites in human blood. Ther Drug Monit. 8, 37–41.PubMedGoogle Scholar
  65. Heazlewood R. L. and Lemass R W. J. (1984) Simple high-performance liquid chromatographic assay for the routine monitoring of clonazepam in plasma. J Chromatogr. Biomed. Appl. 336, 229–233.Google Scholar
  66. Heizmann P., Geschke R, and Zinapold K. (1984) Determination of bromazepam in plasma and of its main metabolites in urine by reversed-phase high-performance liquid chromatography. J Chromatogr. Biomed. Appl. 310, 129–137.Google Scholar
  67. Hequet D., Jarry C, Rouquette C, and Brachet-Liermain A. (1985) Plasma assay of haloperidol by high performance liquid chromatography Ann. Biol. Clin. 43, 739–742.Google Scholar
  68. Hirayama H. and Kasuya Y. (1983) High-performance liquid chromatographic determination of bromazepam in human plasma. J. Chromatogr Biomed Appl. 277, 414–418.Google Scholar
  69. Ho P. C, Triggs E. J, Heazlewood V., and Bourne D. W. A. (1983) Determination of nitrazepam and temazepam in plasma by highperformance liquid chromatography. Ther. Drug Monit. 5, 303–307.PubMedGoogle Scholar
  70. Hojabri H. and Glennon J D. (1985) Determination of cianopramine in human plasma by high-performance liquid chromatography and gas-liquid chromatography with ultraviolet, fluorescence and electron-capture detection. J. Chromatogr. Biomed. Appl. 342, 97–103.Google Scholar
  71. Hubbard J. W., Cooper J. K., Hawes E. M., Jenden D. J., May P. R. A.; Martin M., McKay G, VanPutten T., and Midha K K. (1985) Therapeutic Monitoring of Chlorpromazine. I. Pitfalls in Plasma Analysis. Ther Drug Monit. 7, 222–228PubMedGoogle Scholar
  72. Jatlow P. I., Miller R., and Swigar M (1982) Measurement of haloperidol in human plasma using reversed-phase high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 227, 233–238.Google Scholar
  73. Jewesson P. J. and Remick R. A(1986) Influence of blood collection tubes on tricyclic antidepressant concentration. J Clin. Psychopharmacol. 6, 51–52.PubMedGoogle Scholar
  74. Johnson S. M., Chan C, Cheng S., Shimek J. L.; Nygard G., and Wahba Khalil S. K. (1982) Isocratic high-performance liquid chromatographic method for the determination of tricyclic antidepressants and metabolites in plasma. J. Pharm. Sci. 71, 1027–1030.PubMedGoogle Scholar
  75. Johnson S. M., Nygard G., and Wahba Khalil S. K. (1984) Isocratic liquid chromatographic method for the determination of amoxapme and its metabolites J. Pharm. Sci 73, 696–699.PubMedGoogle Scholar
  76. Jozefczak C, Ktorza N., and Uzan A (1982) High-performance liquid chromatographic determination of mdalpine, a new nontricyclic antidepressant, in human plasma. J. Chromatogr. Biomed. Appl. 230, 87–95.Google Scholar
  77. Kabra P. M and Nzekwe E. U. (1985) Liquid chromatographic analysis of clonazepam in human serum with solid-phase (Bond-Elut) extraction. J Chromatogr Biomed. Appl. 341, 383–390.Google Scholar
  78. Kabra P. M., Stevens G. L., and Marton L. J. (1978) High-pressure liquid chromatographic analysis of diazepam, oxazepam and N-desmethyldiazepam in human blood J. Chromatogr. 150, 355–360.PubMedGoogle Scholar
  79. Kabra P. M., Mar N. A, and Marton L. J. (1981) Simultaneous liquid chromatographic analysis of amitriptyhne, nortriptyline, imipramine, desipramine, doxepin, and nordoxepin. Clin. Chim. Acta iii, 123–132.Google Scholar
  80. Kamimura H., Sasaki H., Yokoi K., and Kawamura S. (1985) Determination of indeloxazine in plasma by liquid chromatography and gas chromatography-mass spectrometry. J Pharm. Sci. 74, 559–561.PubMedGoogle Scholar
  81. Kelly H., Huggett A, and Dawling S. (1982) Liquid-chromatographic measurement of nitrazepam in plasma. Clin. Chem. 28, 1478–1481.PubMedGoogle Scholar
  82. Ketchum C, Robinson C. A., and Scott J W. (1983) Analysis of amoxapine, 8-hydroxyamoxapine, and maprotiline by high-pressure liquid chromatography. Ther Drug Monit. 5, 309–312.PubMedGoogle Scholar
  83. Kilts C. D., Patrick K S., Breese G. R., and Mailman R. B. (1982) Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high performance liquid chromatography on radially compressed silica. J Chromatogr. Biomed Appl. 231, 377–391Google Scholar
  84. Kilts C. D., Dew K. L., Ely T. D, and Mailman R. B. (1985) Quantification of R-(+)-7-chloro-8-hydroxy-l-phenyl-2/3/4,5-tetrahydro-lH-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection J. Chromatogr Biomed. Appl 342, 452–457.Google Scholar
  85. Kimball D. F. and Lampert A. A. (1982) Analysis of amoxapine and its metabolites in human plasma by high pressure liquid chromatography. S.D. J. Med. 35, 31–33.PubMedGoogle Scholar
  86. Kobayashi A., Sugita S., and Nakazawa K. (1985) Determination of amoxapine and its metabolites in human serum by high-performance liquid chromatography. Neuropharmacol. 12, 1253–1256.Google Scholar
  87. Kobayashi A., Sugita S., and Nakazawa K. (1984) High-performance liquid chromatographic determination of imipramine and desipramine in serum. J Chromatogr. Biomed. Appl. 336, 410–414.Google Scholar
  88. Kogan M. J, Pierson D., and Verebey K. (1983) Quantitative determination of haloperidol in human plasma by high-performance liquid chromatography. Ther. Drug Monit. 5, 485–489.PubMedGoogle Scholar
  89. Korpi E. R., Phelps B. H., Granger H., Chang W.-H., Linnoila M., Meek J. L., and Wyatt R. J (1983) Simultaneous determination of halopendol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection Clin. Chem. 29, 624–628PubMedGoogle Scholar
  90. Koteel P., Mullins R. E, and Gadsden R H. (1982) Sample preparation and liquid-chromatographic analysis for tricyclic antidepressants in serum. Clin. Chem 28, 462–466.PubMedGoogle Scholar
  91. Kozu T. (1984) High-performance liquid chromatographic determination of nitrazepam and its metabolites in human urine. J. Chromatogr. Biomed. Appl 310, 213–218.Google Scholar
  92. Kraak J. C. and Bijster P. (1977) Determination of amitriptyline and some of its metabolites in blood by high-pressure liquid chromatography. J Chromatogr Biomed. Appl. 143, 499–512.Google Scholar
  93. Kruger R., Mengel I., and Kuss H. J. (1984) Determination of benperidol in human plasma by high-performance liquid chromatography. J. Chromatogr. Biomed Appl. 311, 109–116.Google Scholar
  94. Kuss H. J. and Feistenauer E. (1981) Quantitative high-performance liquid chromatographic assay for the determination of maprotihne and oxaprotiline in human plasma. J. Chromatogr. 204, 349–353.PubMedGoogle Scholar
  95. Lagerstrom P.-O., Marie I., and Persson B.-A. (1983) Solvent extraction of tricyclic amines from blood plasma and liquid chromatographic determination J. Chromatogr. Biomed Appl 273, 151–160.Google Scholar
  96. Larsen N.-E., Hansen L. B., and Knudsen P. (1985) Quantitative determination of perphenazine and its dealkylated metabolite using high-performance liquid chromatography J. Chromatogr. Biomed. Appl. 341, 244–250.Google Scholar
  97. Larsson M. and Forsman A (1983) A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses. Ther. Drug Montt. 5, 225–228.Google Scholar
  98. Leelavathi D. E., Dressier D. E., Soffer E. F., Yachetti S. D., and Knowles J. A. (1985) Determination of promethazme in human plasma by automated high-performance liquid chromatography with electrochemical detection and by gas chromatography-mass spectrometry J. Chromatogr Biomed Appl. 339, 105–115.Google Scholar
  99. Lensmeyer G L. and Evenson M. A. (1984) Stabilized analysis of antidepressant drugs by solvent-recycled liquid chromatography Procedure and proposed resolution mechanisms for chromatography. Clin Chem 30, 1774–1779.PubMedGoogle Scholar
  100. Lensmeyer G. L., Rajani C, and Evenson M A (1982) Liquidchromatographic procedure for simultaneous analysis for eight benzodiazepines in serum. Chn Chem. 28, 2274–2278.Google Scholar
  101. LeRoux Y., Gaillot J., and Beider A. (1982) High-performance liquid chromatographic determination of pipotiazine in human plasma and urine. J. Chromatogr. Biomed. Appl. 230, 401–408Google Scholar
  102. Lindberg R L P. (1985) Selective and sensitive high-performance liquid chromatographic assay for the metabolites of nomifensine in human plasma. J. Chromatogr Biomed Appl. 341, 333–339Google Scholar
  103. Lindberg R. L. P., Salonen J. S, and Iisalo E I. (1983) Determination of nomifensine in human serum-A comparison of high-performance liquid and gas-liquid chromatography. J. Chromatogr. Biomed. Appl 276, 85–92.Google Scholar
  104. Linnoila M., Dorrity F., and Jobson K. (1978) Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients. Am J. Psychiatry 135, 557–561.PubMedGoogle Scholar
  105. Linnoila M., Insel T., Kilts C, Potter W. Z., and Murphy D. L. (1982) Plasma steady-state concentrations of hydroxylated metabolites of clomipramine. Clin. Pharmacol. Ther 32, 208–211PubMedGoogle Scholar
  106. MacKichan J. J., Jusko W. J., Duffner P. K., and Cohen M. E. (1979) Liquid-chromatographic assay of diazepam and its major metabolites in plasma. Clin Chem 25, 856–859.PubMedGoogle Scholar
  107. McBurney A. and George S (1984) High-performance liquid chromatography of halopendol in serum at the concentrations achieved during chronic therapy. J. Chromatogr. Biomed. Appl 308, 387–392.Google Scholar
  108. McCormick S. R., Nielsen J., and Jatlow P (1984) Quantification of alprazolam in serum or plasma by liquid chromatography. Clin Chem. 30, 1652–1655.PubMedGoogle Scholar
  109. McCutcheon J. R (1979) Reverse-phase HPLC determination of thioridazine and mesoridazine in whole blood. J. Anal Toxicol. 3, 105–107.Google Scholar
  110. Mclntyre I. M., Norman T. R., and Burrows G. D (1981) In vitro stability of nomifensine in plasma. Clin. Chem. 27, 203–204.Google Scholar
  111. McKay G., Geddes J., Cowper M. J., and Gurnsey T. S. (1983) Recent advances in the analysis of phenothiazine drugs and their metabolites using high performance liquid chromatography. Prog. Neuropsychopharmacol. Biol Psychiatry 7, 703–707.PubMedGoogle Scholar
  112. McKay G., Cooper J. K., Hawes E. M., Hubbard J. W, Martin M., and Midha K. K (1985) Therapeutic monitoring of chlorpromazine. II Pitfalls in whole blood analysis. Ther. Drug Monit, 7, 472–477.PubMedGoogle Scholar
  113. Mellstrom B. and Braithwaite R. (1978) Ion-pair liquid chromatography of amitriptyline and metabolites in plasma. J. Chromatogr. 157, 379–385.PubMedGoogle Scholar
  114. Mellstrom B. and Tybring G (1977) Ion-pair liquid chromatography of steady-state plasma levels of chlorimipramine and demethylchlonmipramine. J. Chromatogr. Biomed. Appl. 143, 597–605.Google Scholar
  115. Midha K K., Cooper J. K., McGilveray I. J., Butterfield A. G., and Hubbard J. W. (1981) High-performance liquid chromatographic assay for nanogram determination of chlorpromazine and its comparison with a radioimmunoassay. J. Pharm. Sci 70, 1043–1046.PubMedGoogle Scholar
  116. Miller R. L. and Devane C L. (1986a) Analysis of trazodone and mchlorophenyl piperazine in plasma and brain tissue by highperformance liquid chromatography. J. Chromatogr. Biomed Appl. 374, 388–393.Google Scholar
  117. Miller R. L. and Devane C. L. (1986b) Measurement of haloperidol and reduced haloperidol in human plasma using reversed-phase highperformance liquid chromatography. J. Chromatogr. Biomed. Appl. 374, 405–408.Google Scholar
  118. Miyao Y., Suzuki A., Noda K., and Noguchi H. (1983) A sensitive assay method for pimozide in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. Biomed. Appl. 275, 443–449.Google Scholar
  119. Miyazaki K, Arita T., Oka I., Koyama T., and Yamashita I. (1981) Highperformance liquid chromatographic determination of haloperidol in plasma. J. Chromatogr. Biomed. Appl. 223, 449–453.Google Scholar
  120. Morselli P. L., Bianchetti G., Tedeschi G., and Braithwaite R. A. (1981) Haloperidol: Clinical Pharmacokinetics and Significance of Therapeutic Drug Monitoring, in Therapeutic Drug Monitoring (Richens A. and Marks A., eds.) Churchill Livingstone, Edinburgh.Google Scholar
  121. Moyes R. B and Moyes I. C. A. (1977) Metabolism and pharmacokinetics of clomipramine Measurement of plasma antidepressant levels by high-performance liquid chromatography Postgrad Med. J. 53 (suppl 4), 117–123PubMedGoogle Scholar
  122. Murakami K., Murakami K, and Ueno T (1982) Simultaneous determination of chlorpromazine and levomepromazine in human plasma and urine by high-performance liquid chromatography using electrochemical detection. J. Chromatogr. Biomed. Appl. 227, 103–112.Google Scholar
  123. Naranjo C. A., Abel J G, Sellers E M., and Giles H. G. (1980) Unaltered diazepam plasma binding using indwelling heparinized cannulae for sampling. Br. J. Clin. Pharmacol 9, 103–105.Google Scholar
  124. Narasimhachan N., Dorey R. C, Landa B. L, and Friedel R. O. (1984) Improved high-performance liquid chromatographic method for the quantitation of cis-thiothixene in plasma samples using transthiothixene as internal standard. J Chromatogr. Biomed. Appl. 311, 424–429.Google Scholar
  125. Norman T. R and Maguire K. P. (1985) Analysis of tricylic antidepressant drugs in plasma and serum by chromatographic techniques. J Chromatogr. Biomed. Appl 340, 173–197Google Scholar
  126. Orsulak P. J., Sink M., and Weed J. (1984) Blood-collection tubes for tricyclic antidepressant drugs. A reevaluation Ther Drug Monit. 6, 444–448.PubMedGoogle Scholar
  127. Oyehaug E., Ostensen E T., and Salvesen B. (1982) Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection. J. Chromatogr Biomed. Appl 227, 129–135Google Scholar
  128. Oyehaug E., Ostensen E. T., and Salvesen B. (1984) High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. J. Chromatogr. Biomed. Appl. 308, 199–208.Google Scholar
  129. Pacakova V., Stulik K., and Tomkova H. (1984) Determination of some tricyclic neuroleptics by reversed-phase high-performance liquid chromatography with ultraviolet and polarographic detection. J. Chromatogr. 298, 309–318.PubMedGoogle Scholar
  130. Parkinson D. (1985) Sensitive analysis of butyrophenone neuroleptics by high-performance liquid chromatography with ultraviolet detection at 254 nm J. Chromatogr. Biomed Appl 341, 465–472.Google Scholar
  131. Peat M. A. and Kopjak L. (1979) The screening and quantitation of diazepam, flurazepam, chlordiazepoxide, and their metabolites in blood and plasma by electron-capture gas chromatography and high pressure liquid chromatography. J. Forens. Sci. 24, 46–54.Google Scholar
  132. Peat M. A., Finkle B. S., and Deyman M. E. (1979) High-pressure liquid chromatographic determination of chlordiazepoxide and its major metabolites in biological fluids. J. Pharm Sci. 68, 1467–1468.PubMedGoogle Scholar
  133. Peng G. W. (1984) Assay of admazolam in plasma by liquid chromatography. J Pharm. Sci 73, 1173–1175.PubMedGoogle Scholar
  134. Perchalski R. J. and Wilder B. J. (1978) Determination of benzodiazepme anticonvulsants in plasma by high-performance liquid chromatography. Anal Chem. 50, 554–557PubMedGoogle Scholar
  135. Petters I., Peng D.-R., and Rane A (1984) Quantitation of clonazepam and its 7-amino and 7-acetamido metabolites in plasma by highperformance liquid chromatography. J Chromatogr. Biomed. Appl. 306, 241–248Google Scholar
  136. Proelss H. F., Lohmann H. J., and Miles D. G. (1978) High-performance liquid-chromatographic simultaneous determination of commonly used tricyclic antidepressants. Clin. Chem. 24, 1948–1953.PubMedGoogle Scholar
  137. Przyborowska M., Szumilo H, Misztal G., and Olajossy M. (1982) Determination of chlorpromazme in blood by high-performance liquid chromatography (HPLC) Acta. Pol. Pharm. 42, 467–672Google Scholar
  138. Puglisi C. V and deSilva J. A. F. (1981) Determination of the anxiolytic agent 8-chloro-6-(2-chlorophenyl)-4H-imidazo-[l,5-a.][l,4]-benzodiazepine-3-carboxamide in whole blood, plasma or urine by high-performance liquid chromatography. J Chromatogr Biomed. Appl. 226, 135–146.Google Scholar
  139. Puglisi C. V., Pao J., Ferrara F. J., and deSilva J. A. F. (1985) Determination of midazolam (Versed®) and its metabolites in plasma by highperformance liquid chromatography. J. Chromatogr. Biomed. Appl. 344, 199–209Google Scholar
  140. Quattrocchi F., Karnes H T., Robinson J. D, and Hendeles L. (1983) Effect of serum separator blood collection tubes on drug concentrations. Ther. Drug Monit. 5, 359–362.PubMedGoogle Scholar
  141. Raisys V. A, Friel P. N., Graaff P. R., Opheim K. E., and Wilensky A J (1980) High-performance liquid chromatographic and gas-liquid chromatographic determination of diazepam and nordiazepam in plasma. J. Chromatogr Biomed. Appl. 183, 441–448.Google Scholar
  142. Rao S. N., Dhar A K., Kutt H., and Okamoto M. (1982) Determination of diazepam and its pharmacologically active metabolites in blood by Bond Elut column extraction and reversed-phase high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 231, 341–348.Google Scholar
  143. Ratnaraj N., Goldberg V. D., Elyas A., and Lascelles P. T. (1981) Determination of diazepam and its major metabolites using highperformance liquid chromatography. Analyst 106, 1001–1004.PubMedGoogle Scholar
  144. Ratnaraj N, Goldberg V., and Lascelles P. T. (1984) Determination of clobazam and desmethylclobazam in serum using high-performance liquid chromatography. Analyst 109, 813–815.PubMedGoogle Scholar
  145. Reece P. A., Zacest R., and Barrow C. G. (1979) Quantification of imipramine and desipramine in plasma by high-performance liquid chromatography and fluorescence detection J. Chromatogr. Biomed Appl. 163, 310–314Google Scholar
  146. Root I. and Ohlson G. B. (1984) Trazodone overdose: Report of two cases. / Anal Toxtcol. 8, 91–94.Google Scholar
  147. Rop P. P., Viala A., Durand A., and Conquy T. (1985) Determination of citalopram, amitriptyhne and clomipramine in plasma by reversedphase high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 338, 171–178.Google Scholar
  148. Rop P. P., Conquy T., Gouezo F., Viala A., and Grimaldi F (1986) Determination of metapramine, imipramine, trimipramine and their major metabolites in plasma by reversed-phase column liquid chromatography. J. Chromatogr, Biomed. Appl. 375, 339–347.Google Scholar
  149. Routledge P. A., Kitchell B. B.; Bjornsson T. D, Skinner T., Lmnoila M., and Shand D. G. (1980) Diazepam and N-desmethyl diazepam redistribution after heparin. Cltn. Pharmacol. Ther. 27, 528–532.Google Scholar
  150. Rovei V. and Sanjuan M. (1980) Simple and specific high performance liquid chromatographic method for the routine monitoring of clonazepam in plasma. Ther. Drug Monit. 2, 283–287.PubMedGoogle Scholar
  151. Sajgo M., Gesztesi A., and Sido T (1981) Determination of tofisopam in serum by high-performance liquid chromatography J Chromatogr Biomed. Appl. 222, 303–307.Google Scholar
  152. Salonen J. S. and Scheinin M. (1983) Determination of maprotiline and N-desmethylmaprotiline from biological fluids by HPLC. J. Anal. Toxicol 7, 175–177PubMedGoogle Scholar
  153. Sankey M. G., Holt J E, and Kaye C M. (1982) A simple and sensitive HPLC method for the assay of prochlorperazine in plasma. Br. J. Cltn. Pharmacol. 13, 578–580.Google Scholar
  154. Shaw W., Long G., and McHan J. (1983) An HPLC method for analysis of clonazepam in serum. J. Anal Toxicol 7, 119–122.PubMedGoogle Scholar
  155. Shibanoki S., Kubo T., and Ishikawa K. (1986) Chromatographic assay of 10-[3-(3-hydroxypyrrohdinyl)propyl]-2-trifluoromethyl phenothiazine using electrochemical detection. J. Chromatogr. Biomed. Appl. 377, 436–440.Google Scholar
  156. Silber B., Lo M., and Riegelman S. (1980) The influence of heparin administration on the plasma protein binding and disposition of propranolol. Res. Commun. Chem. Pathol. Pharmacol 27, 419–429.PubMedGoogle Scholar
  157. Skellern G. G., Meier J., Knight B I, and Whiting B (1978) The application of HPLC to the determination of some 1,4-benzodiazepines and their metabolites in plasma Br. J Clin Pharmacol 5, 483–487.PubMedGoogle Scholar
  158. Skinner T., Gochnauer R, and Linnoila M. (1981) Liquid chromatographic method to measure thioridazine and its active metabolites in plasma Acta Pharmacol. Toxicol. 48, 223–226.Google Scholar
  159. Smith D. J. (1981) The separation and determination of chlorpromazine and some of its related compounds by reversed-phase high performance liquid chromatography J, Chromatogr Sci. 19, 65–71.Google Scholar
  160. Smith G. A., Schulz P., Giacomini K. M, and Blaschke T. F. (1982) High-pressure liquid chromatographic determination of amitriptyline and its major metabolites in human whole blood. J. Pharm Sci. 71, 581–583PubMedGoogle Scholar
  161. Sonsalla P. K., Jennison T. A., and Finkle B S (1982a) Quantitative liquid-chromatographic technique for the simultaneous assay of tricylic antidepressant drugs in plasma or serum. Clin Chem. 28, 457–461.PubMedGoogle Scholar
  162. Sonsalla P, Jennsion T., and Finkle B (1982b) Importance of evaporation conditions and two internal standards for quantitation of amitriptyline and nortriptyline Clin. Chem. 28, 1401–1402.PubMedGoogle Scholar
  163. Stoll A. L., Baldessarini R J., Cohen B. M., and Finklestein S. P (1984) Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection. J Chromatogr. Biomed. Appl. 307, 457–463.Google Scholar
  164. Streator J. T., Eichmeier L. S., and Caplis M. E. (1980) Determination of tricylic antidepressants in serum by high pressure liquid chromatography on a silica column J Anal Toxicol 4, 58–62.PubMedGoogle Scholar
  165. Strojny N. and deSilva J. A. F. (1985) Determination of diclofensine, an antidepressant agent, and its major metabolites in human plasma by high-performance liquid chromatography with fluorometric detection. J. Chromatogr Biomed. Appl. 341, 313–331.Google Scholar
  166. Suckow R F. (1983) A simultaneous determination of trazodone and its metabolite 1-m-chlorophenylpiperazine in plasma by liquid chromatography with electrochemical detection. J Ltq. Chromatogr 6, 2195–2208.Google Scholar
  167. Suckow R. F. and Cooper T B. (1981) Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. J. Pharm. Sci. 70, 257–261.PubMedGoogle Scholar
  168. Suckow R G. and Cooper T B. (1982) Simultaneous determination of amitriptyline, nortriptyline and their respective isomeric 10-hydroxy metabolites in plasma by liquid chromatography. J. Chromatogr. Biomed. Appl. 230, 391–400.Google Scholar
  169. Suckow R.G. and Cooper T. B. (1984) Determination of trimipramine and metabolites in plasma by liquid chromatography with electrochemical detection. J Pharm Sci. 73, 1745–1748PubMedGoogle Scholar
  170. Suckow R. F. and Cooper T. B. (1985) Determination of amoxapine and metabolites in plasma by liquid chromatography with electrochemical detection. J. Chromatogr. Biomed. Appl. 338, 225–229.Google Scholar
  171. Suckow R. F., Cooper T. B., Quitkin F. M., and Stewart J. W (1982) Determination of mianserin and metabolites in plasma by liquid chromatography with electrochemical detection. J. Pharm Sci. 71, 889–892.PubMedGoogle Scholar
  172. Sumirtapura Y C, Aubert C, Coassolo P., and Cano J. P. (1982) Determination of 7-amino-flunitrazepam (Ro 20-1815) and 7-aminodesmethylflunitrazepam (Ro 5-4650) in plasma by high-performance liquid chromatography and fluorescence detection. J. Chromatogr. Biomed. Appl 232, 111–118Google Scholar
  173. Sutfin T. A. and Jusko W. J. (1979) High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites. J Pharm. Sci. 68, 703–705.PubMedGoogle Scholar
  174. Sutfin T. A., D’Ambrosio R., and Jusko W. J. (1984) Liquidchromatographic determination of eight tri-and tetracyclic antidepressants and their major active metabolites. Clin, Chem. 30, 471–474.Google Scholar
  175. Tada K., Moroji T, Sekiguchi R., Motomura H., and Noguchi T. (1985) Liquid chromatographic assay of diazepam and its major metabolites in serum, and application to pharmacokinetic study of high doses of diazepam in schizophrenics. Clin. Chem. 31, 1712–1715.PubMedGoogle Scholar
  176. Tasset J. J. and Hassan F M. (1982) Liquid-chromatographic determination of amoxapme and 8-hydroxyamoxapine in human serum. Clin. Chem. 28, 2154–2157.PubMedGoogle Scholar
  177. Taylor E. H., Sloniewsky D., and Gadsden R. H. (1984) Automated extraction and high-performance liquid chromatographic determination of serum clonazepam. Ther Drug Monit. 6, 474–477.PubMedGoogle Scholar
  178. Taylor G. and Houston J. B. (1982) Simultaneous determination of promethazine and two of its circulating metabolites by highperformance liquid chromatography. J. Chromatogr. Biomed Appl 230, 194–198.Google Scholar
  179. Thoma J. J., Bondo P. B., and Kozak C. M. (1979)Tricyclic antidepressants in serum by a Clin-Elut column extraction and high pressure liquid chromatographic analysis. Ther. Drug Monit. 1, 335–358.PubMedGoogle Scholar
  180. Tjaden U. R., Lankelma J, Poppe H, and Muusze R. G. (1976) Anodic coulometric detection with a glassy carbon electrode in combination with reversed-phase high-performance liquid chromatography. J. Chromatogr Biomed. Appl 125, 275–286.Google Scholar
  181. Tjaden U.R., MeelesM T H A., Thys C. P., and Van Der Kaay M. (1980) Determination of some benzodiazepines and metabolites in serum, urine and saliva by high-performance liquid chromatography. J. Chromatogr. Biomed Appl 181, 227–241.Google Scholar
  182. Tomasini J. L., Bun H., Coassolo P., and Aubert C. (1985) Determination of clobazam, N-desmethylclobazam and their hydroxy metabolites in plasma and urine by high-performance liquid chromatography. J Chromatogr. Biomed Appl. 343, 369–377.Google Scholar
  183. Vandermark F. L, Adams R. F., and Schmidt G. J (1978) Liquidchromatographic procedure for tricyclic drugs and their metabolites in plasma. Clin Chem. 24, 87–91Google Scholar
  184. Van Rooij H. H., Waterman R. L., and Kraak J. C. (1979) Dynamic cation-exchange systems for the separation of drugs derived from butyrophenone and diphenylpiperidine by high-performance liquid chromatography and applied in the determination of halopemide in plasma. J. Chromatogr. Biomed. Appl. 164, 177–185Google Scholar
  185. Varian Instruments. Rapid sorbent extraction of tricyclic antidepressants from serum. Sample Preparation Digest No. 2. Sunnyvale, California.Google Scholar
  186. Vasiliades J. and Sahawneh T. H. (1981) Determination of midazolam by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 225, 266–271.Google Scholar
  187. Viala A., Hou N., Durand A., Ba B., Aaes-Jorgensen T., and Jorgensen A. (1983) Dosage du cis(z)-clopenthixol et de la fluphénazine dans le sang total et le plasma par chromatographie en phase liquide à haute performance avec etalonnage interne. J. Pharm. Belg. 38, 299–303.PubMedGoogle Scholar
  188. Violon C, Pessemier L., and Vercruysee A. (1982) High-performance liquid chromatography of benzophenone derivatives for the determination of benzodiazepines in clinical emergencies. J. Chromatogr. 236, 157–168PubMedGoogle Scholar
  189. Visser T., Oostelbos M. C. J. M., and Toll P. J. M. M. (1984) Reliable routine method for the determination of antidepressant drugs in plasma by high-performance liquid chromatography. J. Chromatogr Biomed. Appl. 309, 81–93.Google Scholar
  190. Vree T. B., Baars A M., Hekster Y. A., and Van Der Kleijn E. (1979) Simultaneous determination of diazepam and its metabolites N-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 162, 605–614.Google Scholar
  191. Vree T. B., Baars A. M., Booij L. H. D., and Driessen J. J. (1981) Simultaneous determination and pharmacokinetics of midazolam and its hydroxymetabolites in plasma and urine of man and dog by means of high-performance liquid chromatography. Arzneimittelforsch. 31, 2215–2219.PubMedGoogle Scholar
  192. Wallace J. E., Shimek E. L., and Harris S. C. (1981a) Determination of tricyclic antidepressants by high-performance liquid chromatography. J. Anal. Toxicol. 5, 20–23.PubMedGoogle Scholar
  193. Wallace J. E., Shimek E. L., Harris S. C, and Stavchansky S. (1981b) Determination of promethazine in serum by liquid chromatography. Clin. Chem. 27, 253–255.PubMedGoogle Scholar
  194. Wallace J E., Shimek E. L., Stavchansky S., and Harris S. C. (1981c) Determination of promethazine and other phenothiazine compounds by liquid chromatography with electrochemical detection. Anal. Chem. 53, 960–962.PubMedGoogle Scholar
  195. Watson I. D. and Stewart M. J. (1977) Quantitative determination of amitriptyline and nortriptyline in plasma by high-performance liquid chromatography. J. Chromatogr. 132, 155–159.PubMedGoogle Scholar
  196. Weinfield R. E. and Miller K. F. (1981) Determination of the major urinary metabolite of flurazepam in man by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl 223, 123–130.Google Scholar
  197. Wells C. E., Juenge E. C, and Furman W. B. (1983) Simultaneous assay of thioridazine and its major metabolites in plasma at single dose levels with a novel report of two ring sulfoxides of thiondazine. J. Pharm Sci 72, 622–625.PubMedGoogle Scholar
  198. Westenberg H G. M., Drenth B. F. H., deZeeuw R. A., DeCuyper H., VanPraag H M., and Korf J. (1977a) Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. J. Chromatogr. 142, 725–733PubMedGoogle Scholar
  199. Westenberg H. G. M., de Zeeuw R. A, de Cuyper H., Van Praag H M., and Korf J. (1977b) Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography. Postgrad. Med. J 53 (suppl 4), 124–130.PubMedGoogle Scholar
  200. Westerlund D. and Erixson E. (1979) Reversed-phase chromatography of zimelidine and similar dibasic amines. I. Analysis in biological material. J. Chromatogr. 185, 593–603.PubMedGoogle Scholar
  201. Westerlund D., Nilsson L. B., and Jaksch Y. (1979) Straight-phase ionpair chromatography of zimelidine and similar divalent amines I Bioanalysis. J Ltq Chromatogr 2, 373–405.Google Scholar
  202. Whall T. J. and Dokladalova J (1979) High-performance liquid chromatographic determination of (Z)-and (E)-doxepin hydrochloride isomers. J Pharm Sci 68, 1454–1456.PubMedGoogle Scholar
  203. Wills D. H. and Gelder M. G. (1980) Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. Adv. Biochem. Psychopharmacol. 24, 599–602.Google Scholar
  204. Wong A. S. (1983) An evaluation of HPLC for the screening and quantitation of benzodiazepines and acetaminophen in post mortem blood. J. Anal Toxicol. 7, 33–36.PubMedGoogle Scholar
  205. Wong S H. Y and Waugh S. W (1983) Determination of the antidepressants maprotiline and amoxapine, and their metabolites, in plasma by liquid chromatography. Clin. Chem 29, 314–318.PubMedGoogle Scholar
  206. Wong S. H. Y., Waugh S. W., Draz M., and Jain N (1984) Liquidchromatographic determination of two antidepressants, trazodone and mianserm, in plasma. Clin Chem 30, 230–233.PubMedGoogle Scholar
  207. Wood M., Shand D. G., and Wood A. J.J. (1979) Altered drugbinding due to the use of indwelling heparinized cannulas (heparin lock) for sampling. Clin Pharmacol. Ther. 25, 103–107PubMedGoogle Scholar
  208. Yang S. and Evenson M. A. (1983) Simultaneous liquid chromatographic determination of antidepressant drugs in human plasma. Anal. Chem. 55, 994–998.PubMedGoogle Scholar
  209. Yufu N., Itoh M, Notomi A, and Nakao H. (1984) Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography. Fol Psychiat. Neurol. Jap. 38, 57–64.Google Scholar

Copyright information

© The Humana Press Inc. 1988

Authors and Affiliations

  • Donald F. LeGatt
    • 1
  1. 1.Department of Laboratoy MedicineUnmersity of Alberta HospitalsEdmonton, Alberta

Personalised recommendations